Z79 — ICD-10-CM Diagnosis Codes
- Z79 Long term (current) drug therapy
- Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets
- Z79.01 Long term (current) use of anticoagulants billable
- Z79.02 Long term (current) use of antithrombotics/antiplatelets billable
- Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID) billable
- Z79.2 Long term (current) use of antibiotics billable
- Z79.3 Long term (current) use of hormonal contraceptives billable
- Z79.4 Long term (current) use of insulin billable
- Z79.5 Long term (current) use of steroids
- Z79.51 Long term (current) use of inhaled steroids billable
- Z79.52 Long term (current) use of systemic steroids billable
- Z79.6 Long term (current) use of immunomodulators and immunosuppressants
- Z79.60 Long term (current) use of unspecified immunomodulators and immunosuppressants billable
- Z79.61 Long term (current) use of immunomodulator billable
- Z79.62 Long term (current) use of immunosuppressant
- Z79.620 Long term (current) use of immunosuppressive biologic billable
- Z79.621 Long term (current) use of calcineurin inhibitor billable
- Z79.622 Long term (current) use of Janus kinase inhibitor billable
- Z79.623 Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor billable
- Z79.624 Long term (current) use of inhibitors of nucleotide synthesis billable
- Z79.63 Long term (current) use of chemotherapeutic agent
- Z79.630 Long term (current) use of alkylating agent billable
- Z79.631 Long term (current) use of antimetabolite agent billable
- Z79.632 Long term (current) use of antitumor antibiotic billable
- Z79.633 Long term (current) use of mitotic inhibitor billable
- Z79.634 Long term (current) use of topoisomerase inhibitor billable
- Z79.64 Long term (current) use of myelosuppressive agent billable
- Z79.69 Long term (current) use of other immunomodulators and immunosuppressants billable
- Z79.8 Other long term (current) drug therapy
- Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels
- Z79.810 Long term (current) use of selective estrogen receptor modulators (SERMs) billable
- Z79.811 Long term (current) use of aromatase inhibitors billable
- Z79.818 Long term (current) use of other agents affecting estrogen receptors and estrogen levels billable
- Z79.82 Long term (current) use of aspirin billable
- Z79.83 Long term (current) use of bisphosphonates billable
- Z79.84 Long term (current) use of oral hypoglycemic drugs billable
- Z79.85 Long-term (current) use of injectable non-insulin antidiabetic drugs billable
- Z79.89 Other long term (current) drug therapy
- Z79.890 Hormone replacement therapy billable
- Z79.891 Long term (current) use of opiate analgesic billable
- Z79.899 Other long term (current) drug therapy billable